Clinical trial · Interventional
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
NCT06023368CI-TRIAL-00082516withdrawnPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Administrative burden
Summary
Brief summary (as posted)
The goal of this clinical trial is to compare a sterile vapocoolant spray to EMLA cream in children with access ports. Participants will receive either the spray or cream prior to port access and rate pain on a scale. Researchers will compare spray vs cream to see if the spray is as effective as the cream in reducing pain associated with port puncture.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EMLA Cream | Drug | — | UNRESOLVED |
| Num Vapocoolant Spray | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Sterile Vapocoolant Spray
- description
- Num vapocoolant spray will be administered as a single use canister around the port
- interventionNames
- Drug: Num Vapocoolant Spray
- type
- ACTIVE_COMPARATOR
- label
- EMLA Cream
- description
- Numbing (EMLA) cream will be applied around the port.
- interventionNames
- Drug: EMLA Cream
Primary outcomes (3)
- measure
- Port Access Pain
- timeFrame
- Within 5 minutes of port access
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 4 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * English-speaking * Present appointment is for drawing blood, receiving intravenous antibiotics, blood products, or chemotherapy * EMLA cream has (standard of care) or has not (vapocoolant) been applied to the port site prior to the appointment * Previous allergic reaction or skin irritation due to EMLA * Quick access to the child's port is needed for drawing blood, or giving treatments, blood products, or drugs such as chemotherapy Exclusion Criteria: * Child has a legal guardian or non-parent family member as the only adult with them for the visit. * Children less than 4 years of age * Children with altered mental status * History of traumatic brain injury, developmental delay or autism * Child is nonverbal * Present appointment is for drawing blood, receiving intravenous antibiotics, blood products, or chemotherapy, and child and parents prefer to wait for EMLA cream to take effect.
References
Publications (0)
Data not yet available
No reference posted for this study.